Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration

This study has been completed.
Information provided by (Responsible Party):
Genentech, Inc. Identifier:
First received: March 24, 2003
Last updated: May 14, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):